Retia Medical LLC of Valhalla, NY at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers

Retia Medical LLC

7, Dana Road, Suite 111, 10595 Valhalla, NY
USA

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2021 hall map (Hall 16): stand E34-4

Fairground map

MEDICA 2021 fairground map: Hall 16

Contact

David Hebrank

VP Distribution

Phone
14109603361

Email
dhebrank@retiamedical.com

Morris Nguyen

VP Marketing

Phone
16179168230

Email
mnguyen@retiamedical.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.12  Blood flow measurement equipment

Blood flow measurement equipment

Our products

Product category: Blood flow measurement equipment

Argos Monitor

Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the operating room (OR) and intensive care unit (ICU) with a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-driven patient care decision making.
Equipped with Retia’s proprietary Multi-Beat Analysis (MBATM) algorithm that uses advanced signal processing to improve the model of circulation and enables accurate tracking of both fluid and vasopressor resuscitation, the Argos Monitor seamlessly combines accuracy, ease of use and cost-effectiveness.

Accurate CO monitoring can dramatically improve proactive clinical decision making for high risk surgical and critically ill patients and improves OR and ICU outcomes.1-4 The Argos Monitor provides clinicians with the data required to track oxygen delivery and maintain optimal fluid status. Additionally, by eliminating disposable costs and integrating seamlessly with all vital signs monitors, the Argos Monitor provides a simple and cost-effective solution to making CO monitoring broadly accessible in a greater number of care settings, making CO monitoring a standard of care for more patients.

The Argos Cardiac Output monitoring device is intended for use on patients above the age of 18 years as a hemodynamic monitor for cardiac output monitoring and its derived parameters on patients in the intensive care unit or the operating room.

More Less

About us

Company portrait

RETIA MEDICAL AIMS TO ADVANCE THE USE OF CARDIAC OUTPUT (CO) MONITORING TO IMPROVE PATIENT CARE BY PROVIDING MEMBERS OF THE CRITICAL CARE TEAM WITH A MORE ACCURATE, EASY-TO-USE, AND AFFORDABLE HEMODYNAMIC MONITOR THAT SUPPORTS CONFIDENT, DATA-BASED DECISIONS.

Retia brings together industry-leading expertise in physiology, signal processing and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to giving more clinicians access to CO monitoring by reducing the cost and inconvenience that limit the use of traditional CO technologies to the most high-risk patients.

Retia’s highly accurate, easy-to-use and cost-effective lead product, the Argos Cardiac Output Monitor equipped with the company’s proprietary Multi-Beat Analysis (MBA™) algorithm, guarantees superior CO monitoring performance, quality, reliability, and compatibility for enhanced hemodynamic management. Retia is also developing new algorithms to aid in detecting, diagnosing and treating shock. These include algorithms for calculating ejection fraction and end diastolic volume from arterial lines; predicting and detecting hypotension via non-invasive blood pressure; and calculating continuous CO and left atrial pressure from pulmonary artery pressure waveforms.